Welcome to LookChem.com Sign In|Join Free

CAS

  • or

169758-66-1

Post Buying Request

169758-66-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

169758-66-1 Usage

Uses

NAD 299 Hydrochloride is a selective, high affinity 5-HT1A antagonist, used in psychotropic drug development.

Biological Activity

Selective, high affinity 5-HT 1A receptor antagonist (K i = 0.6 nM in vitro ).

Check Digit Verification of cas no

The CAS Registry Mumber 169758-66-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,9,7,5 and 8 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 169758-66:
(8*1)+(7*6)+(6*9)+(5*7)+(4*5)+(3*8)+(2*6)+(1*6)=201
201 % 10 = 1
So 169758-66-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H23FN2O2/c19-16-8-7-14(18(20)22)15-9-13(10-23-17(15)16)21(11-3-1-4-11)12-5-2-6-12/h7-8,11-13H,1-6,9-10H2,(H2,20,22)/t13-/m1/s1

169758-66-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (3R)-3-[di(cyclobutyl)amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide

1.2 Other means of identification

Product number -
Other names Robalzotan

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:169758-66-1 SDS

169758-66-1Downstream Products

169758-66-1Relevant articles and documents

Process for the manufacture of 3-N-N-dicyclobutylamino-8-fluoro-3, 4-dihydro-2H-1-benzopyran-5-carboxamide

-

, (2008/06/13)

A process for the manufacture of the racemic compound of the formula (I), its R-enantiomer (formula R-(I)) and its S-enantiomer (formula S-(I)), and pharmaceutically acceptable salts and/or solvates thereof, as well as new intermediates obtained and used in the process.

Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist

-

, (2008/06/13)

The invention relates to a combination of a first component (a) which is a 5-HT reuptake inhibitor and a second component (b) which is selective 5-HT 1A antagonist of the general formula wherein R 1 is n-propyl or cyclobutyl; R 2 is isopropyl, tertiary bu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 169758-66-1